RPN1は全がんにおける免疫抑制と関連しており,腫瘍の悪性現象に影響する
Shaoru Lin1, Changwu Wu2,3,4, Qing Liu2,3,4
1Department of Orthopedics, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
まとめ
リボフォリン1 (RPN1) は,ゲノム不安定性と免疫抑制性腫瘍の微環境を促進することによって,がんの進行を促します. そのノックダウンは,がん細胞の成長,移動,侵入を抑制し,RPN1を潜在的な全がん治療標的として強調します.
科学分野:
- 腫瘍学
- 分子生物学
- ガンゲノミクス
背景:
- リボフォリン1 (RPN1) は,グリコシル化に関与するオリゴサカリルトランスフェラーゼ複合体の成分である.
- 糖酸化経路による全がん進行におけるRPN1の役割は,ほとんど研究されていない.
- RPN1の機能を理解することは,新しいがん治療標的を特定するために不可欠です.
研究 の 目的:
- マルチオミクスデータを用いてリボフォリン1 (RPN1) の全がん作用を総合的に分析する.
- RPN1発現と臨床結果,ゲノム変異,腫瘍の微小環境との関連を調査する.
- 癌細胞の行動と治療反応に対するRPN1の影響を機能的に検証する.
主な方法:
- TCGA,GTEx,CPTACからのゲノム,トランスクリプトミクス,プロテオミクスデータを統合したマルチオミクス分析.
- RPN1発現と腫瘍のステージ,予後,ゲノム不安定性マーカー (同種の再結合欠乏症,腫瘍変異負荷),免疫細胞浸透 (CD8+,CD206+M2マクロファージ) の相関分析.
- 増殖,移動,侵入,経路の濃縮を評価するために,マルチプレックス免疫光,共培養測定,およびRPN1ノックダウンを含むインビトロ実験.
主要な成果:
- RPN1は14の悪性腫瘍で有意に過剰発現し,膠原芽細胞腫 (GBM),低度の膠原芽細胞腫,肉腫 (SARC),肝細胞癌の予後が悪かった.
- RPN1増幅は同種の再結合欠乏症と腫瘍変異負荷の増加と相関しており,ゲノム不安定性における役割を果たしていることを示している.
- RPN1の過剰発現はM2マクロファージとコロカライズされ,CD8+T細胞の浸透率の低下と関連しており,特定のがんでは化学療法および免疫療法に対する耐性を予測するが,膀がんではPD-1阻害剤に対する感受性を予測する. RPN1のノックダウンにより GBM細胞の増殖,移動,侵入が抑制されました.
結論:
- RPN1は様々ながんの多様性腫瘍誘発因子として作用し,ゲノム不安定化と免疫抑制性腫瘍の微小環境の再構築に寄与する.
- RPN1の発現は癌細胞のフェノタイプに影響し,化学療法,免疫療法,標的治療に対する反応を調節する.
- RPN1は有望な全がん治療標的であり,状況に依存する脆弱性により,個別化された治療戦略の機会を提供します.
関連する概念動画
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
01:19Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K